The clinical experience of acanthamoeba keratitis at a tertiary care eye hospital

Cornea

Volumn 29, Issue 9, 2010, Pages 1005-1010

  Tanhehco, Tasha ^a,b   Colby, Kathryn ^a,b  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Acanthamoeba keratitis; contact lenses wear; corneal transplant; infectious keratitis epidemiology

Indexed keywords

ACICLOVIR; AMPHOTERICIN; AMPHOTERICIN B; BACITRACIN; CEFAZOLIN; CEFTAZIDIME; CHLORHEXIDINE; CIPROFLOXACIN; DEXAMETHASONE; DEXAMETHASONE PLUS TOBRAMYCIN; ERYTHROMYCIN; FLUCONAZOLE; FRESH WATER; GATIFLOXACIN; ITRACONAZOLE; MOXIFLOXACIN; NEOMYCIN; POLY(HEXAMETHYLENEBIGUANIDE); POLYMYXIN B; PREDNISOLONE ACETATE; PROPAMIDINE; RIMEXOLONE; TOBRAMYCIN; TRIFLURIDINE; VALACICLOVIR; VORICONAZOLE; ANTIPROTOZOAL AGENT;

ACANTHAMOEBA KERATITIS; ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; EPIDEMIC; EYE DISEASE; EYE INJURY; FEMALE; FOLLOW UP; HUMAN; KERATITIS; MALE; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOFT CONTACT LENS; TERTIARY HEALTH CARE; DRUG COMBINATION; HOSPITAL; INCIDENCE; MIDDLE AGED; OPHTHALMOLOGY; PHYSIOLOGY; RISK FACTOR; TREATMENT OUTCOME; VISUAL ACUITY; YOUNG ADULT;

ACANTHAMOEBA KERATITIS; ADOLESCENT; ADULT; AGED; ANTIPROTOZOAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HOSPITALS, SPECIAL; HUMANS; INCIDENCE; KERATOPLASTY, PENETRATING; MALE; MIDDLE AGED; OPHTHALMOLOGY; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; VISUAL ACUITY; YOUNG ADULT;

EID: 77956226229     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3181cf9949     Document Type: Article

References (31)

1. Ibrahim YW, Boase DL, Cree IA. Factors affecting the epidemiology of Acanthamoeba keratitis. Ophthalmic Epidemiol. 2007;14:53-60.
2. Aksozek A, McClellan K, Howard K, et al. Resistance of Acanthamoeba castellanii cysts to physical, chemical, and radiological conditions. J Parasitol. 2002;88:621-623.
3. Ludwig IH, Meisler DM, Rutherford I, et al. Susceptibility of Acantha-moeba to soft contact lens disinfection systems. Invest Ophthalmol Vis Sci. 1986;27:626-628.
4. Stehr-Green JK, Bailey TM, Visvesvara GS. The epidemiology of Acanthamoeba keratitis in the United States. Am J Ophthalmol. 1989;107: 331-336.
5. Awwad ST, Heilman M, Hogan RN, et al. Severe reactive ischemic posterior segment inflammation in Acanthamoeba keratitis. Ophthalmology. 2007;114:313-320.
6. Jones BR, McGill JI, Steele AD. Recurrent suppurative kerato-uveitis with loss of eye due to infection by Acanthamoeba castellani. Trans Ophthalmol Soc U K. 1975;95:210-213.
7. Ficker L, Hunter P, Seal D, et al. Acanthamoeba keratitis occurring with disposable lens wear. Am J Ophthalmol. 1989;108:453.
8. Schaumberg DA, Snow KK, Dana MR. The epidemic of Acanthamoeba keratitis: where do we stand? Cornea. 1998;17:3-10.
9. Hurt M, Proy V, Niederkorn JY, et al. The interaction of Acanthamoeba castellanii cysts with macrophages and neutrophils. J Parasitol. 2003;89: 565-572.
10. Bharathi JM, Srinivasan M, Ramakrishnan R, et al. A study of the spectrum of Acanthamoeba keratitis: a three-year study at a tertiary eye care referral center in South India. Indian J Ophthalmol. 2007;55:37-42.
11. Radford CF, Minasian DC, Dart JK. Acanthamoeba keratitis in England and Wales: incidence, outcome, and risk factors. Br J Ophthalmol. 2002; 86:536-542.
12. Kilvington S, Gray T, Dart J, et al. Acanthamoeba keratitis: the role of domestic tap water contamination in the United Kingdom. Invest Ophthalmol Vis Sci. 2004;45:165-169.
13. Joslin CE, Tu EY, McMahon TT, et al. Epidemiological characteristics of a Chicago-area Acanthamoeba keratitis outbreak. Am J Ophthalmol. 2006;142:212-217.
14. Sun X, Zhang Y, Li R, et al. Acanthamoeba keratitis: clinical characteristics and management. Ophthalmology. 2006;113:412-416.
15. Hammersmith KM. Diagnosis and management of Acanthamoeba keratitis. Curr Opin Ophthalmol. 2006;17:327-331.
16. The Centers for Disease Control and Prevention. Acanthamoeba keratitis\multiple states 2005-2007. MMWR Morb Mortal Wkly Rep. 2007; 56: 532-534.
17. Mathers W. Use of higher medication concentrations in the treatment of Acanthamoeba keratitis. Arch Ophthalmol. 2006;124:923.
18. Sansanayudh W, Cevallos V, Porco TC, et al. Fusarium and Acantha-moeba keratitis: can a single centre detect outbreakš Br J Ophthalmol. 2008;92:720-721.
19. Buck SL, Rosenthal RA, Schlech BA. Amoebicidal activity of multipurpose contact lens solutions. Eye Contact Lens. 2005;31:62-66.
20. Hiti K, Walochnik J, Maria Haller-Schober E, et al. Efficacy of contact lens storage solutions against different Acanthamoeba strains. Cornea. 2006;25:423-437.
21. Shoff ME, Joslin CE, Tu EY, et al. Efficacy of contact lens systems against recent clinical and tap water Acanthamoeba isolates. Cornea. 2008;27: 713-719.
22. Ophthalmic Devices Panel Advisory Meeting, June 10, 2008\Tran-scripts. Gaithersburg, MD: US Food and Drug administration; 2008.
23. Thebpatiphat N, Hammersmith KM, Rocha FN, et al. Acanthamoeba keratitis: a parasite on the rise. Cornea. 2007;26:701-706.
24. Kobayashi A, Ishibashi Y, Oikawa Y, et al. In vivo and ex vivo laser confocal microscopy findings in patients with early-stage Acanthamoeba keratitis. Cornea. 2008;27:439-445.
25. Tu EY, Joslin CE, Sugar J, et al. The relative value of confocal microscopy and superficial corneal scrapings in the diagnosis of Acanthamoeba keratitis. Cornea. 2008;27:764-772.
26. Tu EY, Joslin CE, Sugar J, et al. Prognostic factors affecting visual outcome in Acanthamoeba keratitis. Ophthalmology. 2008;115: 1998-2003.
27. Claerhout I, Goegebuer A, Van Den Broecke C, et al. Delay in diagnosis and outcome of Acanthamoeba keratitis. Graefes Arch Clin Exp Ophthalmol. 2004;242:648-653.
28. Jurkunas U, Behlau I, Colby K. Fungal keratitis: changing pathogens and risk factors. Cornea. 2009;28:638-643.
29. Kashiwabuchi RT, de Freitas D, Alvarenga LS, et al. Corneal graft survival after therapeutic keratoplasty for Acanthamoeba keratitis. Acta Oph-thalmol. 2008;86:666-669.
30. Hiti K, Walochnik J, Faschinger C, et al. One-and two-step hydrogen peroxide contact lens disinfection solutions against Acanthamoeba: how effective are they? Eye. 2005;19:1301-1305.
31. Hasler S, Dedes W, Mathis A, et al. MoisturePlus contact lens solution as a source of Acanthamoeba keratitis. Cornea. 2009;28:219-220.